Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study

Published:2024-08 Issue:8 Volume:56 Page:1312-1318
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Hupé M.,Streichenberger A.,Wils P.,Arab N.,Serrero M.,Amiot A.^ORCID,Bozon A.,Vuitton L.,Fumery M.,Altwegg R.^ORCID,Nachury M.^ORCID,Hébuterne X.,Yzet C.^ORCID,Coban D.,Dodel M.,Bazoge M.,Pereira B.^ORCID,Buisson A.^ORCID

Funder

AbbVie

Publisher

Elsevier BV

Reference25 articles.

1. Ulcerative colitis as a progressive disease: the forgotten evidence;Torres;Inflamm Bowel Dis,2012

2. Ulcerative colitis;Ungaro;Lancet,2017

3. Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease;Shah;Aliment Pharmacol Ther,2016

4. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the international Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD;Turner;Gastroenterology,2020

5. Comparative acceptability of therapeutic maintenance regimens in patients with inflammatory bowel disease: results From the Nationwide ACCEPT2 study;Buisson;Inflamm Bowel Dis,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP